RxSight RXST
NASDAQ RXST
$6.33 -0.12 (-1.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

RxSight (RXST) Gross Margin Growth (3y) (2023 - 2026)

Analysis

RxSight (RXST) Gross Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 264.00
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 104.00
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -89.00
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 459.00
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 8.00
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -316.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 393.00
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 73.00
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 113.00
10 RxSight 265.13 Mn -139.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1,679.00
Dec 31, 2025 3,134.00
Sep 30, 2025 3,739.00
Jun 30, 2025 3,274.00
Mar 31, 2025 3,270.00
Dec 31, 2024 3,754.00
Sep 30, 2024 4,824.00
Jun 30, 2024 8,609.00
Mar 31, 2024 3,797.00
Dec 31, 2023 3,369.00
Sep 30, 2023 4,459.00
Jun 30, 2023 7,525.00